GPATCH8

GPATCH8 is a G-patch domain-containing splicing factor that participates in the quality control of branchpoint selection during pre-mRNA splicing (PMID:38688280). It physically interacts with the RNA helicase DHX15, consistent with the canonical role of G-patch proteins in activating RNA helicases (PMID:38688280). Within the branchpoint quality-control pathway, GPATCH8 functionally antagonizes SUGP1, the two proteins acting in the same pathway with opposing roles during SF3B1-mutant mis-splicing (PMID:38688280). GPATCH8 is required for the aberrant splicing driven by oncogenic SF3B1 mutations: its silencing corrects roughly one-third of mutant SF3B1-dependent splicing defects and improves dysfunctional hematopoiesis in SF3B1-mutant mouse models and primary human hematopoietic progenitors, identifying it as a tractable node in mutant SF3B1 disease biology (PMID:38688280). Beyond these splicing functions, no further mechanistic detail has been characterized in the available corpus.

1. 2004 Low

   Before any functional role was known, the question was simply where GPATCH8 (KIAA0553) is expressed; this established a tissue context but no mechanism.

   Evidence EST frequency analysis of cardiac libraries confirmed by Northern blot

   PMID:15498521

   Open questions at the time

   • Expression-only observation with no functional follow-up
   • No molecular activity or interaction partner identified
   • Differential cardiac expression not linked to any phenotype
2. 2024 High

   A reporter screen and in vivo genetics addressed whether any trans factor is required for oncogenic SF3B1-driven mis-splicing, showing GPATCH8 is necessary and that its loss reverses both splicing defects and hematopoietic dysfunction.

   Evidence Synthetic intron reporter screen, genetic silencing in SF3B1-mutant mouse models and primary human hematopoietic progenitors, splicing analysis

   PMID:38688280

   Open questions at the time

   • Only ~one-third of mis-splicing events corrected, leaving other contributing factors undefined
   • Direct biochemical mechanism of how GPATCH8 acts on the spliceosome not reconstituted
3. 2024 Medium

   To place GPATCH8 mechanistically, its interaction with the RNA helicase DHX15 was examined, linking it to helicase activation during splicing.

   Evidence Protein interaction studies in the context of splicing function characterization

   PMID:38688280

   Open questions at the time

   • Interaction reported without specified Co-IP or pulldown detail and no reciprocal validation
   • Helicase-activating activity inferred from G-patch context rather than directly assayed
4. 2024 Medium

   Epistasis experiments addressed how GPATCH8 relates to other branchpoint factors, establishing it as a functional antagonist of SUGP1 within the same quality-control pathway.

   Evidence Genetic epistasis and functional splicing assays in SF3B1-mutant cellular models

   PMID:38688280

   Open questions at the time

   • Single-lab cellular epistasis without in vitro reconstitution
   • Molecular basis of the antagonism with SUGP1 not defined
   • Whether antagonism operates in wild-type SF3B1 contexts unclear

• The direct biochemical mechanism by which GPATCH8, via DHX15, enforces branchpoint selection quality control and counteracts SUGP1 remains unresolved.
• No in vitro reconstitution of GPATCH8/DHX15 activity on the spliceosome
• No structural model of GPATCH8 within the branchpoint recognition machinery
• Mechanism of antagonism with SUGP1 at the molecular level undefined